chlorethylclonidine has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, NA; Armenia, A; Johns, EJ; Khan, MA; Sattar, MA | 1 |
| Abdul Sattar, M; Johns, EJ | 1 |
2 other study(ies) available for chlorethylclonidine and Goldblatt Syndrome
| Article | Year |
|---|---|
Functional subtypes of renal alpha1-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Clonidine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension, Renovascular; Kidney; Male; Methoxamine; Nitrendipine; Norepinephrine; Phenylephrine; Piperazines; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2008 |
Alpha 1-adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one-clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Animals; Clonidine; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renovascular; Kidney; Male; Methoxamine; Phenylephrine; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Vasoconstriction | 1994 |